Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma

PurposeOur previous study showed that hepatic arterial infusion chemotherapy (HAIC) using oxaliplatin, fluorouracil, and leucovorin (FOLFOX) plus sorafenib provided a significant survival benefit over sorafenib for advanced hepatocellular carcinoma. However, it is unclear whether the survival benefi...

Full description

Bibliographic Details
Main Authors: Run-Bin Liang, Yang Zhao, Min-Ke He, Dong-Sheng Wen, Xiao-Yun Bu, Ye-Xing Huang, Zhi-Cheng Lai, Yu-Jie Xu, Anna Kan, Wei Wei, Yao-Jun Zhang, Min-Shan Chen, Rong-Ping Guo, Qi-Jiong Li, Ming Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
hepatic arterial infusion chemotherapy
FOLFOX
sorafenib
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.619461/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.619461/full

Similar Items